[
  {
    "question": "What were Medtronic's total net sales for the fiscal year ended April 25, 2025?",
    "answer": "For the fiscal year ended April 25, 2025, Medtronic's total net sales were $33.537 billion."
  },
  {
    "question": "What were Medtronic's total net sales for the fiscal year ended April 26, 2024?",
    "answer": "For the fiscal year ended April 26, 2024, Medtronic's total net sales were $32.364 billion."
  },
  {
    "question": "What was the GAAP diluted earnings per share (EPS) for Medtronic in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic's GAAP diluted earnings per share (EPS) was $3.61."
  },
  {
    "question": "What was the GAAP diluted earnings per share (EPS) for Medtronic in fiscal year 2024?",
    "answer": "In fiscal year 2024, Medtronic's GAAP diluted earnings per share (EPS) was $2.76."
  },
  {
    "question": "How much did Medtronic spend on Research and Development in fiscal year 2025?",
    "answer": "Medtronic's research and development expense for fiscal year 2025 was $2.732 billion."
  },
  {
    "question": "What were the net sales for the Cardiovascular Portfolio in fiscal year 2025?",
    "answer": "The Cardiovascular Portfolio had net sales of $12.481 billion in fiscal year 2025."
  },
  {
    "question": "What were the net sales for the Neuroscience Portfolio in fiscal year 2025?",
    "answer": "The Neuroscience Portfolio had net sales of $9.846 billion in fiscal year 2025."
  },
  {
    "question": "What were the net sales for the Medical Surgical Portfolio in fiscal year 2025?",
    "answer": "The Medical Surgical Portfolio had net sales of $8.407 billion in fiscal year 2025."
  },
  {
    "question": "What were the net sales for the Diabetes Operating Unit in fiscal year 2025?",
    "answer": "The Diabetes Operating Unit had net sales of $2.755 billion in fiscal year 2025."
  },
  {
    "question": "How many full-time employees did Medtronic have as of the 2025 report?",
    "answer": "As of the 2025 report, Medtronic has over 95,000 full-time employees."
  },
  {
    "question": "In how many countries does Medtronic operate?",
    "answer": "Medtronic operates in more than 150 countries worldwide."
  },
  {
    "question": "What was the total cost of products sold for Medtronic in fiscal year 2024?",
    "answer": "In fiscal year 2024, the cost of products sold for Medtronic was $11.216 billion."
  },
  {
    "question": "What was the total operating profit for Medtronic in fiscal year 2024?",
    "answer": "Medtronic's operating profit for fiscal year 2024 was $5.144 billion."
  },
  {
    "question": "What were the net sales for the Cranial & Spinal Technologies division in fiscal year 2024?",
    "answer": "The Cranial & Spinal Technologies division had net sales of $4.756 billion in fiscal year 2024."
  },
  {
    "question": "What were the net sales for the Surgical & Endoscopy division in fiscal year 2024?",
    "answer": "The Surgical & Endoscopy division had net sales of $6.508 billion in fiscal year 2024."
  },
  {
    "question": "How much did Medtronic return to shareholders in FY24 through dividends and share repurchases?",
    "answer": "In fiscal year 2024, Medtronic returned $5.5 billion to shareholders through dividends and share repurchases."
  },
  {
    "question": "What was Medtronic's free cash flow in fiscal year 2024?",
    "answer": "Medtronic's free cash flow for fiscal year 2024 was $5.2 billion."
  },
  {
    "question": "What was the organic revenue growth for Medtronic in fiscal year 2024?",
    "answer": "In fiscal year 2024, Medtronic's organic revenue growth was 5.2%."
  },
  {
    "question": "What is the Hugo RAS system?",
    "answer": "The Hugo robotic-assisted surgery (RAS) system is a technology developed by Medtronic designed for a broad range of soft-tissue procedures."
  },
  {
    "question": "What is the GI Genius intelligent endoscopy module?",
    "answer": "The GI Genius intelligent endoscopy module is an AI-powered system used to augment traditional colon cancer screenings by helping to find minuscule, hard-to-detect polyps."
  },
  {
    "question": "What was the non-GAAP diluted EPS for Medtronic in fiscal year 2025?",
    "answer": "The non-GAAP diluted EPS for Medtronic in fiscal year 2025 was $5.49."
  },
  {
    "question": "What was the total debt for Medtronic as of April 25, 2025?",
    "answer": "As of April 25, 2025, Medtronic's total debt was $28.5 billion."
  },
  {
    "question": "What is the purpose of the Symplicity Spyral Renal Denervation (RDN) system?",
    "answer": "The Symplicity Spyral Renal Denervation (RDN) system is a product used to treat hypertension."
  },
  {
    "question": "What is the MiniMed 780G system?",
    "answer": "The MiniMed 780G system is an insulin pump powered by SmartGuard technology that provides smartphone connectivity and automatically adjusts and corrects sugar levels."
  },
  {
    "question": "When did Medtronic announce its intention to separate the Diabetes business?",
    "answer": "Medtronic announced its intention to separate the Diabetes business in May 2025."
  },
  {
    "question": "What was Medtronic's net interest expense in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic's net interest expense was $729 million."
  },
  {
    "question": "Which Medtronic product is described as a leadless transcatheter pacing system?",
    "answer": "The Micra transcatheter pacing system is Medtronic's leadless pacing system."
  },
  {
    "question": "For how many consecutive years had Medtronic increased its dividend as of the 2024 report?",
    "answer": "As of the 2024 report, Medtronic had increased its dividend for 47 consecutive years."
  },
  {
    "question": "What was the year-over-year sales growth for the Neuromodulation division in fiscal year 2025?",
    "answer": "The Neuromodulation division's net sales grew by 11% in fiscal year 2025."
  },
  {
    "question": "What level of pay equity has Medtronic achieved for gender in the United States?",
    "answer": "In the United States, Medtronic has achieved 100% pay equity for gender."
  },
  {
    "question": "What was the total amount of cash and cash equivalents for Medtronic at the end of fiscal year 2025?",
    "answer": "At the end of fiscal year 2025, Medtronic had $2.218 billion in cash and cash equivalents."
  },
  {
    "question": "What were the net sales for the Cardiac Rhythm & Heart Failure division in fiscal year 2025?",
    "answer": "The Cardiac Rhythm & Heart Failure division had net sales of $6.392 billion in fiscal year 2025."
  },
  {
    "question": "What was the value of Medtronic's goodwill as of April 25, 2025?",
    "answer": "As of April 25, 2025, Medtronic's goodwill was valued at $41.737 billion."
  },
  {
    "question": "What was the total operating cash flow for Medtronic in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic's net cash provided by operating activities was $7.044 billion."
  },
  {
    "question": "What is the purpose of the Percept family of neurostimulators?",
    "answer": "The Percept family of neurostimulators, with adaptive BrainSense technology, is used for the treatment of conditions like Parkinson's disease, essential tremor, and refractory epilepsy."
  },
  {
    "question": "How many ordinary shares did Medtronic have outstanding on June 17, 2025?",
    "answer": "On June 17, 2025, Medtronic had 1,281,264,703 ordinary shares outstanding."
  },
  {
    "question": "What was the total amount of dividends paid to shareholders in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic paid a total of $3.589 billion in dividends to shareholders."
  },
  {
    "question": "What is the AiBLE Spine Technology Ecosystem?",
    "answer": "The AiBLE spine technology ecosystem is an integrated portfolio of devices and therapies for surgical technologies designed to improve the precision and workflow of neurological procedures."
  },
  {
    "question": "What was Medtronic's effective tax rate in fiscal year 2025?",
    "answer": "Medtronic's effective tax rate for fiscal year 2025 was 16.6%."
  },
  {
    "question": "What were the net sales for U.S. operations in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic's total net sales in the U.S. were $17.171 billion."
  },
  {
    "question": "What were the net sales for International operations in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic's total net sales from international operations were $16.365 billion."
  },
  {
    "question": "What is the InPen smart insulin pen system?",
    "answer": "The InPen system is a reusable Bluetooth-enabled insulin pen with a mobile app that helps users administer the correct insulin dose and integrates with CGM data."
  },
  {
    "question": "What was the total amount of share repurchases in fiscal year 2025?",
    "answer": "In fiscal year 2025, Medtronic repurchased $3.166 billion of its ordinary shares."
  },
  {
    "question": "Which Medtronic product family includes the Evolut FX+ TAVR system?",
    "answer": "The Evolut FX+ TAVR system is part of the CoreValve family of aortic valves for transcatheter aortic valve replacement."
  },
  {
    "question": "What was the total value of inventories for Medtronic as of April 25, 2025?",
    "answer": "As of April 25, 2025, Medtronic's inventories were valued at $5.476 billion."
  },
  {
    "question": "What is the primary use of the TYRX Absorbable Antibacterial Envelope?",
    "answer": "The TYRX Absorbable Antibacterial Envelope is designed to stabilize electronic implantable devices like pacemakers and defibrillators and help prevent infection."
  },
  {
    "question": "What was the total selling, general, and administrative expense for fiscal year 2025?",
    "answer": "For fiscal year 2025, Medtronic's selling, general, and administrative expense was $10.849 billion."
  },
  {
    "question": "What is the purpose of the InterStim X System?",
    "answer": "The InterStim X system is a neurostimulator used to treat overactive bladder, (non-obstructive) urinary retention, and chronic fecal incontinence."
  },
  {
    "question": "What was the total amount of long-term debt for Medtronic as of April 25, 2025?",
    "answer": "As of April 25, 2025, Medtronic's long-term debt was $25.642 billion."
  },
  {
    "question": "Which Medtronic division develops the PillCam capsule endoscopy systems?",
    "answer": "The PillCam capsule endoscopy systems are developed by the Surgical & Endoscopy division within the Medical Surgical Portfolio."
  }
]